Christian Homsy

65 year

Health Technology

Consumer Services

Process Industries

Active connections

Name	Gender	Age	Linked companies	Collaboration
Michel Lussier	M	67	CELYAD ONCOLOGY SA	17 years
Patrick Jeanmart	M	51	CELYAD ONCOLOGY SA MedPole SA/NV	12 years
Hilde Windels	F	59	CELYAD ONCOLOGY SA	6 years
Evan Castiglia	M	-	Miracor Medical SA Miracor Medical SA Electronic Equipment/InstrumentsElectronic Technology Miracor Medical SA engages in the development and manufacture of medical devices. Its product PICSO (Pressure-controlled Intermittent Coronary Sinus Occlusion) Impulse System has a driving console and associated catheters to improve outcomes for severe heart attack patients. It seeks to increase blood flow to the affected heart tissue, thereby improving the overall heart function after a heart attack. The company was founded by Werner Mohl in May, 2008 and is headquartered in Vienna, Austria.	-
David Georges	M	-	CELYAD ONCOLOGY SA	5 years
Jean-Michel Foidart	M	75	MITHRA PHARMACEUTICALS S.A.	25 years
Olivier Delporte	M	-	Miracor Medical SA Miracor Medical SA Electronic Equipment/InstrumentsElectronic Technology Miracor Medical SA engages in the development and manufacture of medical devices. Its product PICSO (Pressure-controlled Intermittent Coronary Sinus Occlusion) Impulse System has a driving console and associated catheters to improve outcomes for severe heart attack patients. It seeks to increase blood flow to the affected heart tissue, thereby improving the overall heart function after a heart attack. The company was founded by Werner Mohl in May, 2008 and is headquartered in Vienna, Austria.	8 years
Christophe Maréchal	M	-	MITHRA PHARMACEUTICALS S.A.	7 years
Werner Braun	M	77	Miracor Medical SA Miracor Medical SA Electronic Equipment/InstrumentsElectronic Technology Miracor Medical SA engages in the development and manufacture of medical devices. Its product PICSO (Pressure-controlled Intermittent Coronary Sinus Occlusion) Impulse System has a driving console and associated catheters to improve outcomes for severe heart attack patients. It seeks to increase blood flow to the affected heart tissue, thereby improving the overall heart function after a heart attack. The company was founded by Werner Mohl in May, 2008 and is headquartered in Vienna, Austria.	-
Laurence Schyns	F	-	MITHRA PHARMACEUTICALS S.A.	3 years
Fanny Rozenberg	F	-	MITHRA PHARMACEUTICALS S.A.	-
Stijn Vlaminck	M	-	MITHRA PHARMACEUTICALS S.A.	3 years
Eytan Breman	M	-	CELYAD ONCOLOGY SA	9 years
Christoph Naber	M	-	Miracor Medical SA Miracor Medical SA Electronic Equipment/InstrumentsElectronic Technology Miracor Medical SA engages in the development and manufacture of medical devices. Its product PICSO (Pressure-controlled Intermittent Coronary Sinus Occlusion) Impulse System has a driving console and associated catheters to improve outcomes for severe heart attack patients. It seeks to increase blood flow to the affected heart tissue, thereby improving the overall heart function after a heart attack. The company was founded by Werner Mohl in May, 2008 and is headquartered in Vienna, Austria.	-
Malte Kelm	M	-	Miracor Medical SA Miracor Medical SA Electronic Equipment/InstrumentsElectronic Technology Miracor Medical SA engages in the development and manufacture of medical devices. Its product PICSO (Pressure-controlled Intermittent Coronary Sinus Occlusion) Impulse System has a driving console and associated catheters to improve outcomes for severe heart attack patients. It seeks to increase blood flow to the affected heart tissue, thereby improving the overall heart function after a heart attack. The company was founded by Werner Mohl in May, 2008 and is headquartered in Vienna, Austria.	-
Adrian Banning	M	-	Miracor Medical SA Miracor Medical SA Electronic Equipment/InstrumentsElectronic Technology Miracor Medical SA engages in the development and manufacture of medical devices. Its product PICSO (Pressure-controlled Intermittent Coronary Sinus Occlusion) Impulse System has a driving console and associated catheters to improve outcomes for severe heart attack patients. It seeks to increase blood flow to the affected heart tissue, thereby improving the overall heart function after a heart attack. The company was founded by Werner Mohl in May, 2008 and is headquartered in Vienna, Austria.	-
Chong Wang	M	-	Miracor Medical SA Miracor Medical SA Electronic Equipment/InstrumentsElectronic Technology Miracor Medical SA engages in the development and manufacture of medical devices. Its product PICSO (Pressure-controlled Intermittent Coronary Sinus Occlusion) Impulse System has a driving console and associated catheters to improve outcomes for severe heart attack patients. It seeks to increase blood flow to the affected heart tissue, thereby improving the overall heart function after a heart attack. The company was founded by Werner Mohl in May, 2008 and is headquartered in Vienna, Austria.	-
Cedric Darcis	M	-	MITHRA PHARMACEUTICALS S.A.	-
Valérie Gordenne	F	51	MITHRA PHARMACEUTICALS S.A.	3 years
Marina Udier	M	-	CELYAD ONCOLOGY SA	13 years
Benjamin Brands	M	-	MITHRA PHARMACEUTICALS S.A.	15 years
Jacques Galloy	M	53	MITHRA PHARMACEUTICALS S.A.	1 years
Graham Dixon	M	63	MITHRA PHARMACEUTICALS S.A.	5 years
Jean-Manuel Fontaine	M	-	MITHRA PHARMACEUTICALS S.A.	11 years
Thom E. Rasche	M	62	Miracor Medical SA Miracor Medical SA Electronic Equipment/InstrumentsElectronic Technology Miracor Medical SA engages in the development and manufacture of medical devices. Its product PICSO (Pressure-controlled Intermittent Coronary Sinus Occlusion) Impulse System has a driving console and associated catheters to improve outcomes for severe heart attack patients. It seeks to increase blood flow to the affected heart tissue, thereby improving the overall heart function after a heart attack. The company was founded by Werner Mohl in May, 2008 and is headquartered in Vienna, Austria.	-
Serge Goblet	M	-	CELYAD ONCOLOGY SA	16 years
Inge Beernaert	M	-	MITHRA PHARMACEUTICALS S.A.	1 years

Connections Chart

Multi-company connection

Former connections

Name	Gender	Age	Linked companies	Collaboration
Filippo Petti	M	52	CELYAD ONCOLOGY SA	4 years
Patricia van Dijck	M	59	MITHRA PHARMACEUTICALS S.A.	-
William Wijns	M	-	CELYAD ONCOLOGY SA	9 years
Jean-Marc Heynderickx	M	66	CELYAD ONCOLOGY SA	2 years
Frederic Lehmann	M	60	CELYAD ONCOLOGY SA	7 years
Dieter Hauwaerts	M	-	CELYAD ONCOLOGY SA	2 years
Margo Roberts	M	69	CELYAD ONCOLOGY SA	2 years
Christian Moretti	M	78	MITHRA PHARMACEUTICALS S.A.	2 years
Peter de Waele	M	67	CELYAD ONCOLOGY SA	7 years
Erik van den Eynden	M	56	MITHRA PHARMACEUTICALS S.A.	2 years
Debasish Francois Roychowdhury	M	63	CELYAD ONCOLOGY SA	-
Chris de Jonghe	M	-	CELYAD ONCOLOGY SA	4 years
Liesbeth Weynants	F	53	MITHRA PHARMACEUTICALS S.A.	2 years
Sophie Henry	F	-	CELYAD ONCOLOGY SA	-
An Cloet	F	53	MITHRA PHARMACEUTICALS S.A.	2 years
Hanspeter Spek	M	72	CELYAD ONCOLOGY SA	-
Chris Buyse	M	59	CELYAD ONCOLOGY SA	-
Philippe Nobels	M	58	CELYAD ONCOLOGY SA	7 years
Anne Moore	M	-	CELYAD ONCOLOGY SA	-
Peggy Sotiropoulou	M	-	CELYAD ONCOLOGY SA	4 years
Jean-Pierre Latere	M	49	CELYAD ONCOLOGY SA	-
Elena Spanjaard	M	-	CELYAD ONCOLOGY SA	3 years
Georges Rawadi	M	-	CELYAD ONCOLOGY SA	4 years
David Gilham	M	59	CELYAD ONCOLOGY SA	6 years
Steve Buckanavage	M	-	CELYAD ONCOLOGY SA	-
Richard Mountfield	M	-	CELYAD ONCOLOGY SA	-
Alexander M. Milstein	M	65	CELYAD ONCOLOGY SA	-
Pierre Brynaert	M	-	CELYAD ONCOLOGY SA	-
Philippe Dechamps	M	54	CELYAD ONCOLOGY SA	6 years
Warren Sherman	M	-	CELYAD ONCOLOGY SA	-
Gaëtane Metz	M	-	CELYAD ONCOLOGY SA	-
Chris Heymans	M	-	CELYAD ONCOLOGY SA	-
Jaak Minten	M	-	CELYAD ONCOLOGY SA	-
Francis Verhoeye	M	-	CELYAD ONCOLOGY SA	-
Anne Portzenheim	F	-	CELYAD ONCOLOGY SA	-
Gisèle Deblandre	M	-	CELYAD ONCOLOGY SA	-
Gaëtan Servais	M	56	MITHRA PHARMACEUTICALS S.A.	2 years
Roland Gordon-Beresford	M	-	CELYAD ONCOLOGY SA	-
Philippe Ronse	M	-	CELYAD ONCOLOGY SA	-
David Solomon	M	63	MITHRA PHARMACEUTICALS S.A.	1 years
Carri Duncan	M	-	CELYAD ONCOLOGY SA	-
Danny F. Wong	M	61	CELYAD ONCOLOGY SA	-
Amel Tounsi	M	43	MITHRA PHARMACEUTICALS S.A.	2 years

Statistics

Country	Connections	% of total
Belgium	70	100.00%

Age of Connections

Active

Past

Male

Female

Members of the board

Executives

Origin of connections